Glassia 20 mg/ml, Infusionslösung

7680688330021 CH-68833 Infusionslösung
Glassia 20 mg/ml, Infusionslösung
Glassia 20 mg/ml, Infusionslösung
Glassia 20 mg/ml, Infusionslösung
1 / 3
google

Article details

Package size
1
Selling units
1
Measure
Durchstechflasche(n)
Galenic form
Infusionslösung
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
25/08/2025
Summary of Product Characteristics
Français
25/08/2025
Summary of Product Characteristics
Italien
25/08/2025

Detailed composition

Substance Quantity Type Category
(N/A)
1000.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HBESI

Reimbursement information

Public price
CHF 380.35
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/10/2023

Authorization holder

IDEOGEN AG

8807 Freienbach

Authorization information

Swissmedic authorization number
68833
Drug name
Glassia, Infusionslösung
Galenic form
LSINF
ATC Code
B02AB02
Authorization status
Z
Dispensing category
B
First authorization
20/04/2023
Authorization expiration date
19/04/2028
IT Number
06.01.1.
Domain
Human medicine
Field of application
Chronische Augmentations- und Erhaltungstherapie bei Patienten mit klinisch manifestem Emphysem infolge eines schweren hereditären Mangels an Alpha1-PI

Package details

Description (FR)
GLASSIA sol perf 1000 mg/50ml s aigu flac
Description (DE)
GLASSIA Inf Lös 1000 mg/50ml o Nadel Durchstf
Market launch
20/04/2023
Narcotic (BTM)
No

Other package sizes (1)

GLASSIA sol perf 1000 mg/50ml flac 50 ml
None None
GTIN: 7680688330014
View